QRay
Home-based Phototherapeutic Devices for Chronic Wounds
Company Overview
Snapshot
Founded in December 2005, QRay operates with 1–10 employees. The company initiated a skin treatment trial in September 2006, focusing on its phototherapeutic devices.
Business overview
QRay develops and manufactures patient-administered phototherapeutic devices for the treatment of chronic wounds and oral ulcers, as well as for the alleviation of chronic pain conditions. The company's proprietary visible light therapy (VLT) technology utilizes the full spectrum of visible light bandwidths to create a noninvasive, chemical-free approach to healing various disorders. Its flagship product line, Vireo, is a fully adjustable, patient-friendly phototherapy device based on VLT technology, designed for healing and closing chronic wounds through preprogrammed and programmable therapies. QRay operates within the Health Tech & Life Sciences sector, specifically in Medical Devices and Medical Treatment & Therapeutics, serving both B2C and B2B markets.
Strategic signal
In September 2006, QRay began a skin treatment trial for its phototherapeutic devices. This early-stage clinical activity signaled the company's commitment to validating its visible light therapy (VLT) technology for chronic wound treatment, indicating a foundational step towards market entry and product efficacy claims for investors and the medical community.
Company Intelligence Q&A
- What is QRay's core technology?
- QRay's core technology is Visible Light Therapy (VLT), which harnesses the full spectrum of visible light bandwidths to provide a noninvasive and chemical-free approach to treating various disorders, including chronic wounds and oral ulcers.
- What is Vireo?
- Vireo is QRay's flagship product line, a fully adjustable, patient-friendly phototherapy device based on VLT technology. It is designed for healing and closing chronic wounds and offers a variety of preprogrammed and programmable therapies.
- When was QRay founded?
- QRay was founded in December 2005.
- What markets does QRay serve?
- QRay serves both Business-to-Consumer (B2C) and Business-to-Business (B2B) markets with its phototherapeutic devices.
- What was a significant early milestone for QRay?
- In September 2006, QRay began a skin treatment trial for its phototherapeutic devices, marking a key step in the clinical validation of its technology.